SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-079139
Filing Date
2022-12-12
Accepted
2022-12-12 17:02:46
Documents
69
Period of Report
2022-10-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1022_enzobio.htm   iXBRL 10-Q 576278
2 CERTIFICATION f10q1022ex31-1_enzobio.htm EX-31.1 9417
3 CERTIFICATION f10q1022ex31-2_enzobio.htm EX-31.2 9402
4 CERTIFICATION f10q1022ex32-1_enzobio.htm EX-32.1 3781
5 CERTIFICATION f10q1022ex32-2_enzobio.htm EX-32.1 3933
  Complete submission text file 0001213900-22-079139.txt   4251939

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE enz-20221031.xsd EX-101.SCH 55590
7 XBRL CALCULATION FILE enz-20221031_cal.xml EX-101.CAL 42601
8 XBRL DEFINITION FILE enz-20221031_def.xml EX-101.DEF 208881
9 XBRL LABEL FILE enz-20221031_lab.xml EX-101.LAB 458730
10 XBRL PRESENTATION FILE enz-20221031_pre.xml EX-101.PRE 222454
63 EXTRACTED XBRL INSTANCE DOCUMENT f10q1022_enzobio_htm.xml XML 493026
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 221457771
SIC: 8071 Services-Medical Laboratories